TY - JOUR
T1 - Characteristics and prognosis of Japanese female breast cancer patients
T2 - The BioBank Japan project
AU - BioBank Japan Cooperative Hospital Group
AU - Nakamura, Koshi
AU - Okada, Emiko
AU - Ukawa, Shigekazu
AU - Hirata, Makoto
AU - Nagai, Akiko
AU - Yamagata, Zentaro
AU - Kiyohara, Yutaka
AU - Muto, Kaori
AU - Kamatani, Yoichiro
AU - Ninomiya, Toshiharu
AU - Matsuda, Koichi
AU - Kubo, Michiaki
AU - Nakamura, Yusuke
AU - Tamakoshi, Akiko
AU - Harada, Hiromasa
AU - Matsubayashi, Sunao
AU - Komi, Rieko
AU - Misumi, Kazuo
AU - Minami, Shiro
AU - Sugihara, Hitoshi
AU - Kodani, Eitaro
AU - Kanazawa, Akio
AU - Gotoh, Hiromasa
AU - Haruna, Hidenori
AU - Asai, Satoshi
AU - Moriyama, Mitsuhiko
AU - Takahashi, Yasuo
AU - Fujioka, Tomoaki
AU - Obara, Wataru
AU - Mori, Seijiro
AU - Ito, Hideki
AU - Nagayama, Satoshi
AU - Miki, Yoshio
AU - Masumoto, Akihide
AU - Yamada, Akira
AU - Nishizawa, Yasuko
AU - Kodama, Ken
AU - Ugi, Satoshi
AU - Araki, Shinichi
AU - Koretsune, Yukihiro
AU - Taki, Hideki
AU - Nakagawa, Takayuki
N1 - Publisher Copyright:
© 2017 The Authors.
PY - 2017
Y1 - 2017
N2 - Background: Breast cancer is currently the most common type of cancer in Japanese females. Unlike most other types of cancer, breast cancer develops more frequently in middle-aged females than in elderly females. Methods: Of all Japanese female breast cancer patients aged ≥ 20 years whom the BioBank Japan Project originally enrolled between 2003 and 2008, 2034 were registered within 90 days after their diagnosis. We described the lifestyle and clinical characteristics of these patients at study entry. Furthermore, we examined the effect of these characteristics on all-cause mortality. Results: In the female patients registered within 90 days after diagnosis, the frequency of stage 0 or unclassified, stage I, II, III and IV were 11.4%, 47.9%, 37.0%, 2.9% and 0.8%, respectively. The proportion of histological types was 12.9% for non-invasive carcinoma (ductal carcinoma and lobular carcinoma), 81.0% for invasive carcinoma (papillotubular carcinoma, solid tubular carcinoma, scirrhous carcinoma and special types), 0.2% for Paget's diseases and 5.8% for others. Those positive for the estrogen and progesterone receptors accounted for 75.8% and 62.1% of all patients, respectively. Among 1860 female participants registered within 90 days, 218 participants died during 144,54 person-years of follow-up. More advanced stage, elevation of serum carcinoembryonic antigen and carbohydrate antigen 15-3 levels and absence of the estrogen receptor at study entry were crudely associated with an increased risk of all-cause mortality after adjustment for age. Conclusions: This study showed the association of several clinical characteristics with all-cause mortality in female breast cancer patients.
AB - Background: Breast cancer is currently the most common type of cancer in Japanese females. Unlike most other types of cancer, breast cancer develops more frequently in middle-aged females than in elderly females. Methods: Of all Japanese female breast cancer patients aged ≥ 20 years whom the BioBank Japan Project originally enrolled between 2003 and 2008, 2034 were registered within 90 days after their diagnosis. We described the lifestyle and clinical characteristics of these patients at study entry. Furthermore, we examined the effect of these characteristics on all-cause mortality. Results: In the female patients registered within 90 days after diagnosis, the frequency of stage 0 or unclassified, stage I, II, III and IV were 11.4%, 47.9%, 37.0%, 2.9% and 0.8%, respectively. The proportion of histological types was 12.9% for non-invasive carcinoma (ductal carcinoma and lobular carcinoma), 81.0% for invasive carcinoma (papillotubular carcinoma, solid tubular carcinoma, scirrhous carcinoma and special types), 0.2% for Paget's diseases and 5.8% for others. Those positive for the estrogen and progesterone receptors accounted for 75.8% and 62.1% of all patients, respectively. Among 1860 female participants registered within 90 days, 218 participants died during 144,54 person-years of follow-up. More advanced stage, elevation of serum carcinoembryonic antigen and carbohydrate antigen 15-3 levels and absence of the estrogen receptor at study entry were crudely associated with an increased risk of all-cause mortality after adjustment for age. Conclusions: This study showed the association of several clinical characteristics with all-cause mortality in female breast cancer patients.
KW - Breast cancer Stage
KW - Histological type
KW - Hormone receptor
KW - Mortality
UR - http://www.scopus.com/inward/record.url?scp=85029310445&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85029310445&partnerID=8YFLogxK
U2 - 10.1016/j.je.2016.12.012
DO - 10.1016/j.je.2016.12.012
M3 - Article
AN - SCOPUS:85029310445
SN - 0917-5040
VL - 27
SP - S98-S106
JO - Journal of epidemiology
JF - Journal of epidemiology
ER -